2397 — DNA Chip Research Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥10bn
- ¥9bn
- ¥328m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -105 | -128 | -172 | -133 | -361 |
Depreciation | |||||
Non-Cash Items | 0.438 | 0.749 | 1.31 | 11.8 | 24.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.71 | -150 | 72.6 | 31.8 | -18 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -89.5 | -259 | -76 | -73 | -337 |
Capital Expenditures | -37.4 | -53 | -51.4 | -58.7 | -126 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.013 | -42.2 | — | — | -29.3 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -37.3 | -95.2 | -51.4 | -58.7 | -155 |
Financing Cash Flow Items | -0.594 | -1.44 | -0.001 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 564 | -1.44 | 446 | — | 278 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 438 | -356 | 318 | -132 | -214 |